Furthermore, insulin also acts to induce PD-L1 in pancreatic cancer, and while its role in NSCLC is not directly experimentally verified, it suggests a need to investigate insulin signaling and PD-L1 in NSCLC [35]. This evidence concerns the gene CD274 and pancreatic neoplasm.